Curaleaf Holdings, Inc. (CURLF) stock
CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$7.63−0.20 (-2.55%)
Close on Oct 19, 2026Market cap $2.07BP/E –Yield –
Curaleaf revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $1.27B, down 5.0% from the year before. The highest annual figure on record is $1.35B in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.27B | -5.0% |
| FY2024 | Dec 31, 2024 | $1.33B | -0.9% |
| FY2023 | Dec 31, 2023 | $1.35B | +5.6% |
| FY2022 | Dec 31, 2022 | $1.28B | +6.6% |
| FY2021 | Dec 31, 2021 | $1.20B | +90.9% |
| FY2020 | Dec 31, 2020 | $626.64M | +183.5% |
| FY2019 | Dec 31, 2019 | $221.02M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $340.10M | – |
| Q2 FY2025 | Jun 30, 2025 | $310.59M | – |
See a number that looks wrong?